They act as cytotoxic cells against the tumor and hinder immunosuppression within the TME, mainly recruiting and activating CD8+ T cells by the secretion of IL-12, TNF-α, CCL3, CCL9 and CXCL10 [84]. This evidence concerns the gene CD8A and neoplasm.